KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

West Pharmaceutical Services (WST) Shares Repurchased (2016 - 2025)

West Pharmaceutical Services' Shares Repurchased history spans 14 years, with the latest figure at $500000.0 for Q2 2025.

  • For Q2 2025, Shares Repurchased fell 99.73% year-over-year to $500000.0; the TTM value through Dec 2025 reached $134.0 million, down 76.11%, while the annual FY2025 figure was $134.0 million, 76.11% down from the prior year.
  • Shares Repurchased for Q2 2025 was $500000.0 at West Pharmaceutical Services, down from $133.5 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $267.0 million in Q1 2024 and bottomed at -$100000.0 in Q4 2022.
  • The 5-year median for Shares Repurchased is $60.1 million (2023), against an average of $98.2 million.
  • The largest annual shift saw Shares Repurchased skyrocketed 177100.0% in 2023 before it plummeted 99.73% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $137.1 million in 2021, then tumbled by 100.07% to -$100000.0 in 2022, then surged by 177100.0% to $177.0 million in 2023, then tumbled by 69.27% to $54.4 million in 2024, then plummeted by 99.08% to $500000.0 in 2025.
  • Per Business Quant, the three most recent readings for WST's Shares Repurchased are $500000.0 (Q2 2025), $133.5 million (Q1 2025), and $54.4 million (Q4 2024).